marketnews

Breaking News: Nixxy Changes Record Date for Cognogroup Spin-Off – What You Need to Know!

Nixxy, Inc. Withdraws Record Date for Spin-Off of Atlantic Energy Solutions Key Details Nixxy, Inc. announced today that it is withdrawing the previously announced record date for its planned spin-off of its subsidiary, Atlantic Energy Solutions, or CognoGroup, the anticipated future name of the Company following the spinoff. Original Announcement Original Record Date: November 15,…

Read More

Global Ship Lease Announces Quarterly Dividend for 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares

Global Ship Lease Announces Quarterly Dividend for 8.75% Series B Cumulative Redeemable Perpetual Preferred Shares ATHENS, Greece, Dec. 04, 2024 (GLOBE NEWSWIRE) – Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership charter owner, announced today that the Company’s Board of Directors has declared a cash dividend of $0.546875 per depositary share, each representing a…

Read More

Join the Fight for Justice: Elanco Animal Health Inc. Faces Lawsuit for Securities Law Violations – Stand with Affected Investors and the Schall Law Firm

Investors Beware: Elanco Animal Health Incorporated Faces Class Action Lawsuit What You Need to Know It’s always important for investors to stay informed about the companies they invest in, and this is particularly true when it comes to potential legal issues that could impact their investments. The Schall Law Firm is currently reminding investors of…

Read More

FONAR Assets: A Must-Have Investment Opportunity

Charmingly Eccentric: The Case for FONAR as a Value Play Introduction Despite recent underperformance, FONAR remains a value play with minimal debt, positive profitability, and attractive valuation multiples, particularly a P/B ratio of 0.61. Q1-Fiscal 2025 earnings showed a decline, but FONAR’s book value continues to grow, driven by strategic investments in high-field MRI scanners…

Read More

Unlocking the Potential: Ideaya Biosciences’ Promising Pipeline and Strong Financial Backing

Ideaya Biosciences: A Detailed Look at Recent Developments Volatility in Ideaya Biosciences’ Stock Ideaya Biosciences’ stock has experienced significant volatility in recent months, driven by clinical data releases and a secondary offering. Despite these movements, the stock currently trades near its December levels, presenting an interesting opportunity for investors looking to capitalize on the company’s…

Read More